Ontario is the first province to cover a new drug for amyotrophic lateral sclerosis.
Ontario’s placement of Albrioza, made by Massachusetts-based Amylyx Pharmaceuticals, on the province’s public drug plan follows itsMoore said the medication becomes one of three drug therapies available to ALS patients and is “another tool for clinicians to offer.”
It is available under the “exceptional access” category of the Ontario Drug Benefit Program to patients who meet the criteria. Some Ontarians may already have coverage under private drug plans. Moore said she hopes other provinces and territories quickly follow Ontario’s lead. About 3,000 people across the country have ALS and roughly one-third of them die every year.Speaking for Amylyx, head of Canadian operations Chris Aiello hailed Ontario’s move as a “milestone.”
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Ontario 'encouraged' by feds' infrastructure funding promiseFederal Infrastructure Minister Dominic LeBlanc said the Trudeau government is aiming to release its funding allotments to the provinces in the fall
Lire la suite »
Opioid-related deaths surge among Ontario teens, young adults from 2014 to 2021: reportReport finds half of 15- to 24-year-olds had opioid use disorder, meaning many were likely experimenting or using drugs recreationally before they died
Lire la suite »
MintList auction platform makes bid for dealers in OntarioAuto tech startup MintList will launch its used-vehicle auction and trade-in platform in Ontario in mid-July, as the Vancouver-based company takes its first step outside Western Canada.
Lire la suite »
Opioid death rates tripled for Ontario teens, young adults since 2014, research showsTORONTO - Opioid-related deaths among teens and young adults in Ontario tripled from 2014 to 2021, while drug treatment rates significantly decreased,...
Lire la suite »
Opioid death rates tripled for Ontario teens, young adults since 2014, research showsOpioid-related deaths among teens and young adults in Ontario tripled from 2014 to 2021, while drug treatment rates significantly decreased, a new report shows.
Lire la suite »